Daewoong pharmaceutical Co.,Ltd (069620.KS)
069620.KS Stock Price Chart
Explore Daewoong pharmaceutical Co.,Ltd interactive price chart. Choose custom timeframes to analyze 069620.KS price movements and trends.
069620.KS Company Profile
Discover essential business fundamentals and corporate details for Daewoong pharmaceutical Co.,Ltd (069620.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Sept 2005
Employees
1.73K
Website
https://www.daewoong.comCEO
Chang-Jae Lee
Description
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
069620.KS Financial Timeline
Browse a chronological timeline of Daewoong pharmaceutical Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 28 Oct 2025
Earnings released on 31 Jul 2025
EPS came in at ₩3.28K , while revenue for the quarter reached ₩405.45B , beating expectations by +7.91%.
Earnings released on 28 Apr 2025
EPS came in at ₩1.90K falling short of the estimated ₩2.33K by -18.32%, while revenue for the quarter reached ₩356.49B , missing expectations by -0.92%.
Earnings released on 10 Feb 2025
EPS came in at -₩1.12K falling short of the estimated ₩2.38K by -146.95%, while revenue for the quarter reached ₩367.88B , beating expectations by +1.53%.
Dividend declared on 27 Dec 2024
A dividend of ₩600.00 per share was announced, adjusted to ₩600.00. The dividend was paid on 1 Apr 2025.
Earnings released on 30 Oct 2024
EPS came in at ₩2.46K surpassing the estimated ₩2.34K by +5.00%, while revenue for the quarter reached ₩358.47B , beating expectations by +6.19%.
Earnings released on 9 Aug 2024
EPS came in at ₩99.00 falling short of the estimated ₩2.22K by -95.55%, while revenue for the quarter reached ₩360.54B , beating expectations by +8.86%.
Earnings released on 29 Apr 2024
EPS came in at ₩708.00 falling short of the estimated ₩1.47K by -51.74%, while revenue for the quarter reached ₩335.79B , beating expectations by +7.91%.
Earnings released on 5 Feb 2024
EPS came in at ₩5.74K surpassing the estimated -₩204.00 by +2.91K%, while revenue for the quarter reached ₩361.82B , beating expectations by +9.87%.
Earnings released on 27 Oct 2023
EPS came in at ₩1.35K , while revenue for the quarter reached ₩340.90B , beating expectations by +2.92%.
Earnings released on 27 Jul 2023
EPS came in at ₩2.15K surpassing the estimated ₩1.33K by +62.17%, while revenue for the quarter reached ₩350.19B , beating expectations by +8.54%.
Earnings released on 3 May 2023
EPS came in at ₩1.38K falling short of the estimated ₩1.39K by -0.53%, while revenue for the quarter reached ₩322.41B , beating expectations by +5.11%.
Earnings released on 15 Feb 2023
EPS came in at -₩844.62 falling short of the estimated ₩2.23K by -137.93%, while revenue for the quarter reached ₩327.78B , beating expectations by +6.50%.
Dividend declared on 28 Dec 2022
A dividend of ₩600.00 per share was announced, adjusted to ₩600.00. The dividend was paid on 7 Apr 2023.
Earnings released on 31 Oct 2022
EPS came in at ₩1.85K surpassing the estimated ₩1.84K by +0.48%, while revenue for the quarter reached ₩331.89B , beating expectations by +6.75%.
Earnings released on 16 Aug 2022
EPS came in at ₩1.58K falling short of the estimated ₩1.80K by -12.09%, while revenue for the quarter reached ₩322.06B , beating expectations by +7.57%.
Earnings released on 16 May 2022
EPS came in at ₩1.23K falling short of the estimated ₩1.30K by -5.20%, while revenue for the quarter reached ₩298.36B , beating expectations by +5.43%.
Earnings released on 15 Feb 2022
EPS came in at ₩2.77K surpassing the estimated ₩2.11K by +31.48%, while revenue for the quarter reached ₩303.02B , beating expectations by +6.68%.
Dividend declared on 29 Dec 2021
A dividend of ₩600.00 per share was announced, adjusted to ₩600.00. The dividend was paid on 8 Apr 2022.
Earnings released on 3 Nov 2021
EPS came in at ₩991.00 falling short of the estimated ₩1.37K by -27.44%, while revenue for the quarter reached ₩290.65B , missing expectations by -27.44%.
Earnings released on 29 Jul 2021
EPS came in at ₩553.00 falling short of the estimated ₩732.78 by -24.53%, while revenue for the quarter reached ₩289.69B .
Earnings released on 6 May 2021
EPS came in at -₩2.14K falling short of the estimated ₩342.74 by -724.09%, while revenue for the quarter reached ₩269.62B .
Earnings released on 15 Feb 2021
EPS came in at ₩1.65K falling short of the estimated ₩2.40K by -31.48%, while revenue for the quarter reached ₩267.24B .
Dividend declared on 29 Dec 2020
A dividend of ₩600.00 per share was announced, adjusted to ₩600.00. The dividend was paid on 9 Apr 2021.
Earnings released on 4 Nov 2020
EPS came in at ₩223.00 falling short of the estimated ₩702.05 by -68.24%, while revenue for the quarter reached ₩276.83B .
069620.KS Stock Performance
Access detailed 069620.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.